SPHINGOTEC GMBH

sphingotec-gmbh-logo

SphingoTec is a biomaker company that develops and markets in vitro diagnostic solutions for novel and proprietary blood-based protein biomarkers. They also develop microtiter plates, which are a standard tool in analytical research and diagnostic testing laboratories. They develop biomakers to address diagnostically underserved critical care conditions such as acute kidney injury, sepsis, and acute heart failure.

#SimilarOrganizations #People #Financial #Event #Website #More

SPHINGOTEC GMBH

Social Links:

Industry:
Biotechnology

Founded:
2002-01-01

Address:
Hohen Neuendorf, Brandenburg, Germany

Country:
Germany

Website Url:
http://www.sphingotec.com

Total Employee:
11+

Status:
Active

Total Funding:
1.5 M EUR

Technology used in webpage:
Domain Not Resolving SPF DMARC Newsletter2Go


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

flobio-logo

FloBio

FloBio develops point-of-care diagnostics for bleeding risk based on real-time blood analysis.

invisible-sentinel-logo

Invisible Sentinel

At Invisible Sentinel, we develop first in class, next generation technologies for a safer food supply.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

4teen4-pharmaceuticals-logo

4TEEN4 Pharmaceuticals

4TEEN4 Pharmaceuticals develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.

Current Employees Featured

jรถrg-menten_image

Jรถrg Menten
Jรถrg Menten CEO @ Sphingotec GmbH
CEO
2022-07-01

andreas-bergmann_image

Andreas Bergmann
Andreas Bergmann Founder & CSO @ Sphingotec GmbH
Founder & CSO
2022-07-01

Founder


andreas-bergmann_image

Andreas Bergmann

Investors List

hbm-partners_image

HBM Partners

HBM Partners investment in Series B - Sphingotec GmbH

hbm-healthcare-investments-ag_image

HBM Healthcare Investments

HBM Healthcare Investments investment in Series B - Sphingotec GmbH

hbm-healthcare-investments-ag_image

HBM Healthcare Investments

HBM Healthcare Investments investment in Convertible Note - Sphingotec GmbH

hbm-partners_image

HBM Partners

HBM Partners investment in Convertible Note - Sphingotec GmbH

hbm-healthcare-investments-ag_image

HBM Healthcare Investments

HBM Healthcare Investments investment in Convertible Note - Sphingotec GmbH

Official Site Inspections

http://www.sphingotec.com Semrush global rank: 15.62 M Semrush visits lastest month: 2

  • Host name: nis-p0-proxy-01.neusta-is.de
  • IP address: 185.48.220.211
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Sphingotec GmbH"

Meet our Team - sphingotec.com

Deborah Bergmann has been an integral part of SphingoTec's journey from its inception, contributing significantly across various domains, including research and development, โ€ฆSee details»

About Us - sphingotec.com

SphingoTec is a privately held company with its headquarter in Hennigsdorf near Berlin and with a wholly-owned subsidiary in San Diego, USA. The headquarter has a long history of biomarker โ€ฆSee details»

Sphingotec GmbH - Crunchbase Company Profile

SphingoTec is a biomaker company that develops and markets in vitro diagnostic solutions for novel and proprietary blood-based protein biomarkers. They also develop microtiter plates, which are a standard tool in analytical research and โ€ฆSee details»

Sphingotec , LLC: Contact Details and Business Profile

IVD tests for SphingoTec's proprietary biomarkers are made available as sphingotest® microtiter plate tests as well as point-of-care tests on the Nexus IB10 immunoassay platform. โ€ฆSee details»

4TEEN4 Pharmaceuticals - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number +49 33 02/2 05 65-0 4TEEN4 Pharmaceuticals GmbH is a biopharmaceutical company developing Procizumab, a humanized antibody โ€ฆSee details»

SphingoTec Company Overview, Contact Details & Competitors

Innovative Biomarkers SphingoTec develops cutting-edge biomarkers for acute medical conditions and health risks, presenting opportunities to collaborate with healthcare providers โ€ฆSee details»

SphingoTec Company Profile - Office Locations, Competitors

SphingoTec is a company that develops biomarkers for diagnosis, prediction, and monitoring of acute medical conditions. It focuses on acute heart failure, acute kidney injury, and circulatory โ€ฆSee details»

Sphingotec - HBM Partners

Sphingotec develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in โ€ฆSee details»

SphingoTec - LinkedIn

SphingoTec | 2,308 followers on LinkedIn. Improving patient outcomes with innovative diagnostics for acute care: Actionable insights in real-time | SphingoTec GmbH develops innovative biomarkers ...See details»

Sphingotec - Overview, News & Competitors | ZoomInfo.com

Sphingotec. Software · <25 Employees. Sphingotec GmbH is a company that operates in the Cosmetics industry. It employs 11-20 people and has $1M-$5M of revenue. Read More. View โ€ฆSee details»

Sphingotec - VentureRadar

Sphingotec aims to develop diagnostic methods for prediction, prevention, intervention strategies and early treatment of diseases in the fields of cancer, cardiovascular diseases and kidney โ€ฆSee details»

SphingoTec - Company Profile - Tracxn

Nov 7, 2024 SphingoTec ranks 3rd among 123 active competitors. 40 of its competitors are funded while 16 have exited. Overall, SphingoTec and its competitors have raised over $836M โ€ฆSee details»

Sphingotec Company Profile 2024: Valuation, Funding & Investors

Sphingotec has raised $52.6M. Who are Sphingotecโ€™s investors? Think.Health , Deutsche Biotech Innovativ , Gründerstipendium NRW , Therabel Group, and HBM Healthcare Investments are โ€ฆSee details»

SphingoTec - Technology Networks

SphingoTec develops and markets innovative <i>in vitro</i> diagnostics solutions for novel and proprietary blood-based protein biomarkers. Their aspiration is to translate scientific โ€ฆSee details»

What is SphingoTec? Company Culture, Mission, Values

SphingoTec FAQ. All answers shown come directly from SphingoTec Reviews and are not edited or altered. See questions about. Coworkers; What are co-workers like at SphingoTec? Sep 14, โ€ฆSee details»

Investor Relations - sphingotec.com

SphingoTec is a privately held company with a long history of biomarker discovery, development and validation. We are the legal manufacturer of the CE IVD microtiter plate assays. โ€ฆSee details»

Sphingotec GmbH - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Sphingotec GmbH . 2: โ€ฆSee details»

sphingotec Announces Collaboration with Mayo Clinic for โ€ฆ

Dec 1, 2017 About sphingotec. The biotechnology company SphingoTec GmbH, headquartered in Hennigsdorf, Germany, was founded in 2002. sphingotec aims to reduce or eliminate the โ€ฆSee details»

Scientific Publications - sphingotec.com

SphingoTec's biomarker discovery is based on the highest standard of evidence, with over 100 publications, over 100 clinical studies, and more than 100.000 patients enrolled. Browse our โ€ฆSee details»

linkstock.net © 2022. All rights reserved